YD Bio Ltd (YDES)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

3 annual periodsNewest to oldest
202520242023
Revenue$596,817$510,360$350,131
Gross profit$167,410$155,356$153,445
Research & development$1.6M$491,353
Operating expenses$5.4M$1.6M$163,292
Operating income−$5.3M−$1.5M−$9,847
Net income−$8.3M−$1.4M$13,560
Basic EPSper diluted share-$0.12-$0.02$0.00
Diluted EPSper diluted share-$0.12-$0.02$0.00

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.